Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17065584rdf:typepubmed:Citationlld:pubmed
pubmed-article:17065584lifeskim:mentionsumls-concept:C0021294lld:lifeskim
pubmed-article:17065584lifeskim:mentionsumls-concept:C0728731lld:lifeskim
pubmed-article:17065584lifeskim:mentionsumls-concept:C0008495lld:lifeskim
pubmed-article:17065584lifeskim:mentionsumls-concept:C2754997lld:lifeskim
pubmed-article:17065584lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:17065584pubmed:issue6lld:pubmed
pubmed-article:17065584pubmed:dateCreated2006-11-22lld:pubmed
pubmed-article:17065584pubmed:abstractTextIntrauterine infection is associated with chorioamnionitis (CAM), which can lead to preterm delivery. We previously reported that the levels of IgM and the incidence of CAM were elevated in preterm infants with neonatal pulmonary emphysema. The pathogen and target of this IgM remain unclear. By using Western blot and amino acid sequences, we have determined one of the target proteins: annexin A2. Immunohistochemical analysis showed that annexin A2 was expressed at fetal chorion and amnion membranes. Among very low birth weight (VLBW) infants with hyper-IgM (> or = 30 mg/dL), 58.8% showed a high titer against annexin A2 (more than x 16), which accounted for about 20%-40% of the total IgM. Anti-annexin A2 IgM antibody inhibited plasmin generation. Furthermore, the median of anti-annexin A2 IgM titer from preterm infants who were delivered with high-grade (grade III) CAM was significantly higher than those from preterm infants without CAM (p = 0.011) and with low-grade CAM (grade I and II) (p = 0.010). Here, we indicate the fetal autoimmunoreactivity against the fetomaternal interface in preterm infants.lld:pubmed
pubmed-article:17065584pubmed:languageenglld:pubmed
pubmed-article:17065584pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065584pubmed:citationSubsetIMlld:pubmed
pubmed-article:17065584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17065584pubmed:statusMEDLINElld:pubmed
pubmed-article:17065584pubmed:monthDeclld:pubmed
pubmed-article:17065584pubmed:issn0031-3998lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:YamadaMinoruMlld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:SekiguchiKiyo...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:YanagiharaIta...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:NakayamaMasah...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:SueharaNoriyu...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:FujimuraMasan...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:KitajimaHiroy...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:NishiharaMasa...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:MoritaAkihiro...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:YanagiharaKei...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:HiranoShinyaSlld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:TabataAtsushi...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:NambaFumihiko...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:MatsunamiKats...lld:pubmed
pubmed-article:17065584pubmed:authorpubmed-author:KimotoAkihito...lld:pubmed
pubmed-article:17065584pubmed:issnTypePrintlld:pubmed
pubmed-article:17065584pubmed:volume60lld:pubmed
pubmed-article:17065584pubmed:ownerNLMlld:pubmed
pubmed-article:17065584pubmed:authorsCompleteYlld:pubmed
pubmed-article:17065584pubmed:pagination699-704lld:pubmed
pubmed-article:17065584pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:meshHeadingpubmed-meshheading:17065584...lld:pubmed
pubmed-article:17065584pubmed:year2006lld:pubmed
pubmed-article:17065584pubmed:articleTitleAnti-annexin A2 IgM antibody in preterm infants: its association with chorioamnionitis.lld:pubmed
pubmed-article:17065584pubmed:affiliationDepartment of Developmental Infectious Diseases, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka 594-1101, Japan.lld:pubmed
pubmed-article:17065584pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17065584pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:302entrezgene:pubmedpubmed-article:17065584lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17065584lld:entrezgene
lhgdn:association:35955lhgdn:found_inpubmed-article:17065584lld:lhgdn